Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL8375150

CN(C)C(=O)Oc1cnccc1N.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 2/20 0.39
GAA P10253 2/20 0.39
GLA P06280 1/20 0.39
NCEH1 Q6PIU2 3/20 0.39
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
RAB9A P51151 2/20 0.37
MEN1 O00255 1/20 0.36
KDM6B O15054 1/20 0.36
KDM4A O75164 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
KMT2A Q03164 1/20 0.36
KDM4D Q6B0I6 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8375858 0.90 KDM4E (0.46) KDM4EALDH1A1GAAGLANCEH1
Trifluoroacetic Acid SCHEMBL8375149 0.76 L3MBTL1 (0.42) KDM4EALDH1A1GAAGLAMEN1
SCHEMBL8375135 0.74 MEN1 (0.49) KDM4EALDH1A1GAAGLALMNA
SCHEMBL4633602 0.74 ALDH1A1 (0.48) KDM4EALDH1A1GAAGLAMEN1
SCHEMBL4634558 0.73 KDM4E (0.51) KDM4EALDH1A1GAAGLASMN1; SMN2
SCHEMBL28281678 0.70 KDM4E (0.44) KDM4EALDH1A1GAAGLAMEN1
Trifluoroacetic Acid SCHEMBL6595462 0.69 AOC1 (0.44) KDM4EALDH1A1GAAGLAMEN1
Trifluoroacetic Acid SCHEMBL29952721 0.68 L3MBTL1 (0.42) KDM4EALDH1A1GAAGLAMEN1
SCHEMBL28007495 0.68 NCEH1 (0.58) ALDH1A1NCEH1LMNASMN1; SMN2RAB9A
SCHEMBL17644390 0.66 ITGB1 (0.39) KDM4EGAANCEH1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5821239-A USEFUL FOR TREATING ALZHEIMER'S DISEASE CAUSED BY CHOLINERGIC DEFICIT FROMMER LAWRENCE & HUAG LLP (US) 1998-10-13 US claimed
US-5869480-A ALLEVIATING MEMORY DYSFUNCTION CHARACTERIZED BY CHOLINERGIC DEFICIT HOECHST MARION ROUSSEL INC. (US) 1999-02-09 US disclosed
US-5866565-A ALZHEIMER'S DISORDERS HOECHST MARION ROUSSEL INC. (US) 1999-02-02 US disclosed
US-5821239-A USEFUL FOR TREATING ALZHEIMER'S DISEASE CAUSED BY CHOLINERGIC DEFICIT FROMMER LAWRENCE & HUAG LLP (US) 1998-10-13 US disclosed
EP-0477903-A2 Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-04-01 EP disclosed